SCHEMBL4640536

SCHEMBL4640536

CCC(CCC(C)C)OC(=O)c1cc(C)c(Br)cc1C(=O)OC(CC)CCC(C)C

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.39
PRKCD Q05655 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
HPGD P15428 2/20 0.33
THRA P10827 2/20 0.33
THRB P10828 2/20 0.33
ALDH1A1 P00352 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 2/20 0.32
MAPT P10636 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
PKM P14618 1/20 0.31
PTPN2 P17706 1/20 0.31
PTPN1 P18031 1/20 0.31
PTPN11 Q06124 1/20 0.31
UTS2R Q9UKP6 1/20 0.31
ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4641117 0.95 PRKCA (0.36) PRKCAPRKCDL3MBTL1HPGDTHRA
SCHEMBL4640542 0.95 PRKCA (0.36) PRKCAPRKCDL3MBTL1HPGDTHRA
SCHEMBL4639861 0.90 PRKCA (0.43) PRKCAPRKCDL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL4627358 0.89 PRKCA (0.50) PRKCAPRKCDL3MBTL1HPGDALDH1A1
SCHEMBL4640065 0.88 PRKCA (0.40) PRKCAPRKCDL3MBTL1HPGDTHRA
SCHEMBL4640503 0.86 PRKCA (0.39) PRKCAPRKCDL3MBTL1HPGDTHRA
SCHEMBL4639954 0.85 PRKCA (0.38) PRKCAPRKCDL3MBTL1HPGDTHRA
SCHEMBL4640632 0.84 PRKCA (0.40) PRKCAPRKCDL3MBTL1UTS2RADRA1A
SCHEMBL4639863 0.84 PRKCA (0.40) PRKCAPRKCDL3MBTL1HPGDALDH1A1
SCHEMBL4641097 0.84 ALDH1A1 (0.39) PRKCAPRKCDL3MBTL1THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX PRKCA 1200/4885PRKCD 552/4885L3MBTL1 4720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.